COLONY GROUP LLC - NOVOCURE LTD ownership

NOVOCURE LTD's ticker is NVCR and the CUSIP is G6674U108. A total of 318 filers reported holding NOVOCURE LTD in Q2 2022. The put-call ratio across all filers is 1.26 and the average weighting 0.1%.

Quarter-by-quarter ownership
COLONY GROUP LLC ownership history of NOVOCURE LTD
ValueSharesWeighting
Q3 2023$1,452
-62.3%
89,926
-3.0%
0.02%
-60.0%
Q2 2023$3,849
+1530.9%
92,753
+2258.9%
0.06%
+1733.3%
Q1 2023$236
-96.9%
3,932
-96.2%
0.00%
-97.2%
Q4 2022$7,611
-99.9%
103,763
+13.0%
0.11%
-13.0%
Q3 2022$6,974,000
+9.0%
91,793
-0.3%
0.12%
+11.8%
Q2 2022$6,401,000
-12.0%
92,096
+5.0%
0.11%
+0.9%
Q1 2022$7,270,000
+17.3%
87,749
+6.3%
0.11%0.0%
Q4 2021$6,199,000
-34.8%
82,568
+1.0%
0.11%
-40.1%
Q3 2021$9,501,000
-51.6%
81,782
-7.5%
0.18%
-53.3%
Q2 2021$19,616,000
+57.5%
88,433
-6.1%
0.39%
+48.9%
Q1 2021$12,452,000
-26.8%
94,206
-4.2%
0.26%
-33.3%
Q4 2020$17,022,000
+50.7%
98,370
-3.0%
0.39%
+33.7%
Q3 2020$11,293,000
+79.2%
101,458
-4.5%
0.29%
+61.5%
Q2 2020$6,303,000
-15.4%
106,283
-3.9%
0.18%
-24.8%
Q1 2020$7,448,000
-23.1%
110,609
-3.8%
0.24%
-1.2%
Q4 2019$9,689,000
+9.2%
114,979
-3.1%
0.24%
-13.1%
Q3 2019$8,875,000
+1.3%
118,687
-14.4%
0.28%
+1.4%
Q2 2019$8,765,000138,6270.28%
Other shareholders
NOVOCURE LTD shareholders Q2 2022
NameSharesValueWeighting ↓
Invus Financial Advisors, LLC 470,884$27,923,00010.09%
Darsana Capital Partners LP 1,700,000$100,810,0005.98%
HARTLINE INVESTMENT CORP/ 336,617$19,961,0004.18%
Rhenman & Partners Asset Management AB 375,000$22,238,0002.40%
MORGAN JESS S & CO INC 35,942$2,131,0002.31%
Soleus Capital Management, L.P. 56,397$3,344,0001.91%
Bullseye Asset Management LLC 45,161$2,678,0001.43%
Taylor Frigon Capital Management LLC 46,304$2,746,0001.36%
COURAGE CAPITAL MANAGEMENT LLC 10,000$593,0001.09%
Redwood Investments, LLC 192,986$11,444,0001.01%
View complete list of NOVOCURE LTD shareholders